Science & Technology
Technology Platform Fueling the Research and Development of Drug Candidates
Nano-YBODYTM platform
- 2022-11-16 21:17:31
- 113
Nano-YBODYTM platform is designed to develop symmetric tetravalency BsAbs based on single-domain antibodies. The well-designed structure enables Nano-YBODYTM molecules to achieve higher binding affinity, better stability, lower immunogenicity and higher production yield rate than other BsAbs. YZYBIO has discovered and developed Y400 and Y332 based on the technologies of our Nano-YBODYTM platform. The Company has transferred the rights of Y400 to CMS Vision, which demonstrates the market recognition of the Company’s R&D capabilities.
